Advances in Hematological Malignancies
Recent decades have witnessed remarkable progress in the domain of hematological malignancies. Novel therapies such as targeted therapy, immunotherapies, and therapy are revolutionizing the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative strategies, offering promise for more curative treatment options